Status:
COMPLETED
Compensatory Behavior of E-cig Users in Response to Reduced Nicotine E-liquids
Lead Sponsor:
Rochester Institute of Technology
Conditions:
Healthy
Nicotine Addiction
Eligibility:
All Genders
21+ years
Phase:
EARLY_PHASE1
Brief Summary
The goal of this clinical trial is to learn if low nicotine eliquids work to reduce exposure to nicotine, in addicted ecig users, without increasing consumption of other harmful constituents. The mai...
Detailed Description
This project will investigate whether and how e-cig users compensate puff topography, lung inhalation, and cumulative consumption in response to reduced nicotine eliquid. The project is conducted in t...
Eligibility Criteria
Inclusion
- 21 years or older
- Regular 30-day e-cig users
Exclusion
- Intention to quit using e-cigs within the next 30 days
- Use of other tobacco products in addition to e-cigs on more than 9 of the previous 30 days
- History of acute or chronic asthma
- Previous diagnosis of cancer
- Other chronic medical conditions
- Use of chronic prescription medications
- Pneumonia in prior six weeks
- Upper respiratory tract infection or other febrile illness in previous 2 weeks
- Smokers on antioxidants, or anti-inflammatory therapy
- Pregnant women or women who intend to become pregnant or breast-feeding
- Had Covid-19 in the past 2 months or still feeling effects from a Covid-19 illness
Key Trial Info
Start Date :
July 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2023
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06602492
Start Date
July 15 2021
End Date
November 15 2023
Last Update
September 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rochester Institute of Technology
Rochester, New York, United States, 14623